Regeneron Pharmaceuticals Inc REGN:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 12:23 PM EDT
649.10quote price arrow up+2.15 (+0.33%)
Volume
191,708
52 week range
441.00 - 686.62
Loading...
  • Open646.95
  • Day High649.82
  • Day Low640.02
  • Prev Close646.95
  • 52 Week High686.62
  • 52 Week High Date09/03/21
  • 52 Week Low441.00
  • 52 Week Low Date03/04/21

Key Stats

  • Market Cap69.428B
  • Shares Out106.96M
  • 10 Day Average Volume0.70M
  • Dividend-
  • Dividend Yield-
  • Beta0.18
  • YTD % Change34.27

KEY STATS

  • Open646.95
  • Day High649.82
  • Day Low640.02
  • Prev Close646.95
  • 52 Week High686.62
  • 52 Week High Date09/03/21
  • 52 Week Low441.00
  • 52 Week Low Date03/04/21
  • Market Cap69.428B
  • Shares Out106.96M
  • 10 Day Average Volume0.70M
  • Dividend-
  • Dividend Yield-
  • Beta0.18
  • YTD % Change34.27

RATIOS/PROFITABILITY

  • EPS (TTM)55.70
  • P/E (TTM)11.65
  • Fwd P/E (NTM)13.52
  • EBITDA (MRQ)6.939B
  • ROE (MRQ)51.32%
  • Revenue (MRQ)12.384B
  • Gross Margin (MRQ)86.85%
  • Net Margin (MRQ)50.11%
  • Debt To Equity (MRQ)17.83%

EVENTS

  • Earnings Date11/03/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Related Video

VIDEO3:1203:12
Antibody drugs take off in new Covid surge

Profile

MORE
Regeneron Pharmaceuticals, Inc. is a biotechnology company that discovers, invents, develops, manufactures and commercializes medicines for the treatment of serious diseases. The Company commercializes medicines and product candidates for eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, pain, infectious diseases, and rare diseases. The Company's marketed products include EYLEA (aflibercept) Injection, Dupixent (dupilumab)...
P. Roy Vagelos M.D.
Chairman
Leonard Schleifer M.D., Ph.D.
President
George Yancopoulos M.D., Ph.D.
Co-President
Robert Landry
Chief Financial Officer
Daniel Van Plew
Executive Vice President
Address
777 Old Saw Mill River Rd
Tarrytown, NY
10591-6717
United States

Top Peers

SYMBOLLASTCHG%CHG
BIIB
Biogen Inc
291.28-4.26-1.44%
BNTX
BioNTech SE
343.22+1.87+0.55%
ILMN
Illumina Inc
435.23+0.47+0.11%
GRFS
Grifols SA
15.48-0.12-0.77%
SYNH
Syneos Health Inc
95.47+1.62+1.73%